India Resurgence’s Acquisition of API and CRAMS Business of Ind Swift Laboratories

Khaitan & Co advised India Resurgence Fund on the deal.India Resurgence Fund completed the acquisition of active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS)…

This content is for Standard 1 Year members only.
Login Join Now
Maha Kanaan

Author: Maha Kanaan

This content is for Standard 1 Year members only.
Login Join Now